R&D Systems™ Recombinant Mouse IFN-alpha 13 Protein

Description

Carrier Free Recombinant Protein

Measured in an anti-viral assay using L-929 mouse fibroblast cells infected with encephalomyocarditis (EMC) virus. Vogel, S.N. et al. (1982) Infect. Immunol. 38:681. The ED50 for this effect is 1-15 ng/mL.

Specifications

• Accession Number: Q80SU4.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 3447
• Molecular Weight (g/mol): M.W.-observed: 20-30 kDa, under reducing conditions, M.W.-theoretical: 19 kDa
• Quantity: 10 μg
• Source: Human embryonic kidney cell, HEK293-derived mouse IFN-alpha 13 protein Gly23-Glu189
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: IFL, IFNA1, IFNA13, IFNalpha 13, IFN-alpha 1 b, IFN-alpha-1/13, interferon alpha-1/13, Interferon alpha-D, interferon, alpha 13, LeIF D
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 100 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: IFN-alpha 13